The Food and Drug Administration approved Beyfortus, an injection for infants and children up to 2 years old who face increased risk of severe RSV.
Original article: https://www.reviewjournal.com/life/health/new-drug-to-protect-babies-and-toddlers-from-rsv-gets-fda-approval-ahead-of-cold-season-2873335/
